4.7 Review

How the Tumor Micromilieu Modulates the Recruitment and Activation of Colorectal Cancer-Infiltrating Lymphocytes

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

TGF-β orchestrates the phenotype and function of monocytic myeloid-derived suppressor cells in colorectal cancer

Luciana Gneo et al.

Summary: Monocytic myeloid-derived suppressor cells (M-MDSCs) are expanded in colorectal cancer (CRC) patients, inhibiting T cell proliferation. Blocking IL-10 released by HLA-DR- cells abrogates the suppressive function of M-MDSCs. Tumour conditioned media (TCM) reduces HLA-DR expression, increases IL-10 release, and promotes monocyte suppressive activity. TGF-beta in TCM drives monocyte immunosuppressivity and is enriched at the invasive margin of CRC.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)

Article Immunology

CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer

Yuanyi Yue et al.

Summary: This study aimed to identify TME-related hub genes and prognostic biomarkers in colorectal adenoma (CRAD). The results showed that CX3CR1 played a crucial role in immune cell infiltration and macrophage polarization, and may serve as a prognostic biomarker in colorectal cancer (CRC).

FRONTIERS IN IMMUNOLOGY (2022)

Article Oncology

Ketogenesis Attenuates KLF5-Dependent Production of CXCL12 to Overcome the Immunosuppressive Tumor Microenvironment in Colorectal Cancer

Ruozheng Wei et al.

Summary: This study identifies ketogenesis as a critical regulator of the tumor microenvironment in colorectal cancer and suggests the potential for ketogenic diets as a metabolic strategy to overcome immunosuppression and prolong survival.

CANCER RESEARCH (2022)

Article Oncology

Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies

Md Sanower Hossain et al.

Summary: Colorectal cancer (CRC) is a highly lethal disease with increasing incidence and mortality worldwide. Early detection and treatment are essential for survival, but recurrence and drug resistance pose significant challenges. This comprehensive review addresses the development, risk factors, and management strategies of CRC. In addition, natural products as potential therapeutics are also discussed. Public awareness is crucial for improving CRC management, especially in developing countries where access to diagnosis and treatment resources is limited.

CANCERS (2022)

Article Oncology

Comparison of Immune Response Assessment in Colon Cancer by Immunoscore (Automated Digital Pathology) and Pathologist Visual Scoring

Isabelle Boquet et al.

Summary: The immune response in colon cancer patients varies greatly and has clinical relevance. Comparing Immunoscore (IS) and pathologist visual scoring, this study found low agreement among pathologists and weak concordance between the two methods. The heterogeneity of immune infiltrate leads to inconsistent interpretation among pathologists, making non-standardized methods unlikely to replicate IS results. Introducing immune response as a biomarker for colon cancer prognosis improves prediction accuracy, and the standardized IS assay outperforms expert pathologist assessment in the clinical setting.

CANCERS (2022)

Article Gastroenterology & Hepatology

PU.1-driven Th9 Cells Promote Colorectal Cancer in Experimental Colitis Models Through Il-6 Effects in Intestinal Epithelial Cells

Katharina Gerlach et al.

Summary: This study identified expanded IL-9 and PU.1-expressing mucosal Th9 cells in colorectal cancer patients, with especially high levels in patients with colitis-associated neoplasias. IL-9 and PU.1 promoted tumor growth in vivo, while GATA3 inactivation did not affect Th9-mediated tumor growth. IL-9 regulated tumor growth by controlling claudin2/3 expression and IL-6 production by T cells in colorectal tumors.

JOURNAL OF CROHNS & COLITIS (2022)

Article Biochemistry & Molecular Biology

Blockade of IL-6 inhibits tumor immune evasion and improves anti-PD-1 immunotherapy

Wenyi Li et al.

Summary: This study reveals the significant role of IL-6 in tumor evasion and highlights a novel target to improve the efficacy of immunotherapy in colorectal cancer (CRC). IL-6 overexpression is associated with poor prognosis in CRC. IL-6 deficiency reduces tumor development in mice and leads to high expression of CD8+ T cells in tumors. Furthermore, IL-6 blockade enhances the sensitivity of CRC to anti-PD-1 therapy.

CYTOKINE (2022)

Article Medicine, Research & Experimental

Remodeling the tumor microenvironment via blockade of LAIR-1 and TGF-β signaling enables PD-L1-mediated tumor eradication

Lucas A. Horn et al.

Summary: Collagens in the ECM play dual roles in tumor immune infiltration by acting as a physical barrier and ligand for immune inhibitory receptors. TGF-beta contributes to ECM shaping by stimulating collagen production and remodeling. Targeting ECM components along with immune checkpoint blockade therapy shows promising results in achieving high cure rates and long-term tumor-specific protection.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Article Medicine, Research & Experimental

Histone methyltransferase WHSC1 loss dampens MHC-I antigen presentation pathway to impair IFN-γ stimulated antitumor immunity

Jiale Ren et al.

Summary: IFN-gamma signaling has opposing effects on tumor immunity, stimulating MHC-I antigen presentation while enhancing the PD-L1 checkpoint pathway. This study shows that the loss of a histone dimethyltransferase called WHSC1 impairs the antitumor effect of IFN-gamma signaling by downregulating MHC-I expression. WHSC1 promotes MHC-I gene expression through its interaction with NLRC5, and its expression is correlated with enhanced MHC-I expression and favorable disease outcomes in colorectal cancer.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Review Oncology

Utilizing chemokines in cancer immunotherapy

Florian Markl et al.

Summary: This review discusses the pleiotropic functions of chemokines in the tumor microenvironment and strategies of utilizing chemokines or chemokine antagonism in immunotherapy to improve treatment efficacy.

TRENDS IN CANCER (2022)

Article Pharmacology & Pharmacy

VEGFR2-targeted antibody fused with IFNαmut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity

Pengzhao Shang et al.

Summary: A novel anti-VEGFR2-IFN alpha mutant protein was designed in this study to target VEGFR2, demonstrating specific inhibition of tumor cell proliferation, promotion of apoptosis, and suppression of migration and invasion of colorectal cancer cells through the PI3K-AKT-GSK3 beta-snail signaling pathway. This mutant protein also showed superior anti-tumor efficacy by enhancing dendritic cell maturation, activity, and increasing tumor-infiltrating CD8(+) T cells in the tumor microenvironment, providing a potential new approach to cancer immunotherapy.

ACTA PHARMACEUTICA SINICA B (2021)

Review Biochemistry & Molecular Biology

Cell Therapy for Colorectal Cancer: The Promise of Chimeric Antigen Receptor (CAR)-T Cells

Cristina Aparicio et al.

Summary: Colorectal cancer is a major global public health issue, and CAR-T cell therapy shows promise as a cancer treatment, but faces challenges in achieving success in solid tumors like colon cancer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer

Carmine Stolfi et al.

Summary: The human gastrointestinal tract contains the largest population of immune cells in the body. Transforming growth factor (TGF)-beta 1 plays a crucial role in the immune response of the gut mucosa, and defects in TGF-beta 1 production and signaling can lead to diseases such as immune-inflammatory pathologies, fibrosis, and cancer.

BIOMOLECULES (2021)

Article Oncology

Prognostic Immune-Related Analysis Based on Differentially Expressed Genes in Left- and Right-Sided Colon Adenocarcinoma

Jun-Nan Guo et al.

Summary: By analyzing and screening the differentially expressed genes between LCCs and RCCs, we constructed a PRSM that could predict the prognosis of LCCs and RCCs, and identified five prognostic key IRGs associated with better prognosis.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

Inflammatory Mediators and Gut Microbial Toxins Drive Colon Tumorigenesis by IL-23 Dependent Mechanism

Janani Panneerselvam et al.

Summary: The Western-style diet high in fat is a major cause of obesity and increased risk of colon cancer, with inflammatory molecules playing a key role in the connection between obesity and colon tumorigenesis. IL-23 is significant in the impact of a Western-style diet on obesity, gut microbiome, and colon tumorigenesis, suggesting it as a potential target for prevention and treatment. Pro-inflammatory eicosanoids and gut bacterial toxins facilitate IL-23 production, which is crucial in the progression of obesity-associated colon tumors.

CANCERS (2021)

Article Cell Biology

Poly(I:C) enhances the efficacy of phagocytosis checkpoint blockade immunotherapy by inducing IL-6 production

Cheng Zhong et al.

Summary: The study demonstrates that Poly(I:C) enhances the antitumor activity of CD47 blockade in colorectal cancer by inducing the production of IL-6, which promotes the necessary signaling for macrophage phagocytosis. This finding provides a new strategy for combinational cancer immunotherapy.

JOURNAL OF LEUKOCYTE BIOLOGY (2021)

Review Immunology

Targeting Immune Cell Trafficking - Insights From Research Models and Implications for Future IBD Therapy

Maximilian Wiendl et al.

Summary: Inflammatory bowel diseases such as Crohn's disease (CD) and ulcerative colitis (UC) are multifactorial diseases with an increasing prevalence and incidence worldwide. Targeting immune cell homing has become an important pillar of IBD therapy, with potential for further therapeutic interventions. Leukocyte trafficking and tissue-derived chemokines offer untapped resources for potential therapeutic interventions in IBD.

FRONTIERS IN IMMUNOLOGY (2021)

Article Oncology

Clinical Significance of Chemokine Receptor CXCR4 and CCR7 mRNA Expression in Patients With Colorectal Cancer

Shinsuke Nagasawa et al.

Summary: In patients with colorectal cancer, high expression of CCR7 mRNA is associated with larger tumor size and poorer outcomes. Overexpression of CCR7 mRNA may serve as an independent prognostic factor in patients with colorectal cancer.

ANTICANCER RESEARCH (2021)

Review Oncology

Tumor promoting capacity of polymorphonuclear myeloid-derived suppressor cells and their neutralization

Christopher Groth et al.

Summary: This review summarizes the origin of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) and their relation to classical neutrophils, outlining their metastasis promoting features and promising strategies for targeting them to enhance the efficacy of cancer immunotherapy.

INTERNATIONAL JOURNAL OF CANCER (2021)

Article Gastroenterology & Hepatology

Association of gene and protein expression and genetic polymorphism of CC chemokine ligand 4 in colorectal cancer

Levar Shamoun et al.

Summary: This study demonstrated that CCL4 levels in CRC tissue and the CCL4 gene polymorphism rs10491121, particularly in the right colon, are associated with the clinical outcome of CRC patients. High CCL4 expression in CRC tissue was linked to better survival outcomes, while plasma CCL4 levels were elevated in CRC patients compared to healthy controls. The analysis also highlighted differences in CCL4 gene polymorphism between localized and disseminated disease, with potential implications for prognosis.

WORLD JOURNAL OF GASTROENTEROLOGY (2021)

Article Oncology

Integrin β7 Inhibits Colorectal Cancer Pathogenesis via Maintaining Antitumor Immunity

Youhua Zhang et al.

Summary: ITGB7 expression is decreased in colorectal cancer, and high expression is associated with longer patient survival, higher cytotoxic immune cell infiltration, lower somatic copy number alterations, decreased mutation frequency of APC and TP53, and better response to immunotherapy.

CANCER IMMUNOLOGY RESEARCH (2021)

Review Immunology

IL-35 Regulates the Function of Immune Cells in Tumor Microenvironment

Kewei Liu et al.

Summary: IL-35, a heterodimeric cytokine, plays important roles in the tumor microenvironment by promoting tumor growth, metastasis, and exhibiting immunosuppressive activity. Regulating immune cells can impact tumor-related phenotypes, and targeting IL-35 may offer potential strategies for inhibiting tumor growth.

FRONTIERS IN IMMUNOLOGY (2021)

Review Immunology

Emerging Complexity in CD4+T Lineage Programming and Its Implications in Colorectal Cancer

Daniel DiToro et al.

Summary: The intestinal immune system plays a crucial role in protecting the epithelial layer from pathogens and inflammation, which could lead to diseases such as colorectal cancer. CD4(+)T cells have a diverse range of functions in regulating intestinal inflammation, including both suppression and promotion. The heterogeneity of CD4(+)T cells in colorectal cancer and their dynamic responses offer potential opportunities for targeted intervention strategies.

FRONTIERS IN IMMUNOLOGY (2021)

Article Oncology

CXCR6 is required for antitumor efficacy of intratumoral CD8+ T cell

Binglin Wang et al.

Summary: This study revealed that CXCR6 is exclusively expressed on intratumoral CD8(+) T cells, which are more immunocompetent and possess stronger antitumor activity. Additionally, CXCR6 may serve as a biomarker for tumor immunotherapy.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Oncology

Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer

Kaisa Lehtomaki et al.

Summary: Colorectal cancer is the third most common cancer worldwide. Elevated post-adjuvant CEA, IL-6, and CRP are associated with impaired survival, and IL-6 can identify recurrences in patients with normal CEA. The lead time is shortest for CEA.

CANCERS (2021)

Article Medicine, General & Internal

The Relationship between Inflammation Markers (CRP, IL-6, sCD40L) and Colorectal Cancer Stage, Grade, Size and Location

Olga Martyna Koper-Lenkiewicz et al.

Summary: The study found that evaluation of CRP concentration in CRC patients may have prognostic advantages as it comprehensively reflects clinicopathological features of the tumor. Various factors such as platelet count, tumor location, tumor size, etc., may influence CRP concentration.

DIAGNOSTICS (2021)

Review Immunology

The inflammatory pathogenesis of colorectal cancer

Mark Schmitt et al.

Summary: The research on colorectal cancer indicates the importance of an inflammatory microenvironment for tumorigenesis, which influences the activation of immune cells and stromal cells, as well as the role of intestinal microbiome in tumor development. Chronic inflammation can initiate tumorigenesis, and tumor-elicited and therapy-induced inflammation are also implicated in promoting colorectal cancer.

NATURE REVIEWS IMMUNOLOGY (2021)

Review Gastroenterology & Hepatology

Colon cancer and immunotherapy-can we go beyond microsatellite instability?

Rimini Breakstone

Summary: Immune checkpoint blockade has shown significant efficacy in various tumor types, especially in patients with DNA mismatch repair defects. However, its effectiveness in colon cancer patients is limited, with ongoing research aiming to improve outcomes for those with proficient DNA mismatch repair.

TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Multidisciplinary Sciences

TGF-β signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancer

Laura Garcia Perez et al.

NATURE COMMUNICATIONS (2020)

Article Medicine, Research & Experimental

CX3CR1-CD8+ T cells are critical in antitumor efficacy but functionally suppressed in the tumor microenvironment

Takayoshi Yamauchi et al.

JCI INSIGHT (2020)

Article Hematology

Tumor inhibition or tumor promotion? The duplicity of CXCR3 in cancer

Eleonora Russo et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2020)

Article Oncology

Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment

Susannah L. Hewitt et al.

CLINICAL CANCER RESEARCH (2020)

Review Biochemistry & Molecular Biology

The Role of Interleukins in Colorectal Cancer

Jingjing Li et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)

Article Medicine, Research & Experimental

Intrinsic β-catenin signaling suppresses CD8+ T-cell infiltration in colorectal cancer

Junli Xue et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Article Oncology

Cancer treatment and survivorship statistics, 2019

Kimberly D. Miller et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2019)

Review Immunology

IFN-γ: A cytokine at the right time, is in the right place

J. Daniel Burke et al.

SEMINARS IN IMMUNOLOGY (2019)

Review Biochemistry & Molecular Biology

IL-23 in inflammatory bowel diseases and colon cancer

Markus F. Neurath

CYTOKINE & GROWTH FACTOR REVIEWS (2019)

Article Multidisciplinary Sciences

TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis

Daniele V. F. Tauriello et al.

NATURE (2018)

Article Multidisciplinary Sciences

β7 integrins contribute to intestinal tumor growth in mice

Srustidhar Das et al.

PLOS ONE (2018)

Article Medicine, Research & Experimental

Targeting Interleukin-6 (IL-6) Sensitizes Anti-PD-L1 Treatment in a Colorectal Cancer Preclinical Model

Jibin Li et al.

MEDICAL SCIENCE MONITOR (2018)

Review Gastroenterology & Hepatology

Roles for Interleukin 17 and Adaptive Immunity in Pathogenesis of Colorectal Cancer

Christopher G. Hurtado et al.

GASTROENTEROLOGY (2018)

Article Gastroenterology & Hepatology

Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer

F. Amicarella et al.

Review Cell Biology

Role of chemokine receptors and intestinal epithelial cells in the mucosal inflammation and tolerance

Neeraja Kulkarni et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2017)

Article Immunology

The effect of CT26 tumor-derived TGF-β on the balance of tumor growth and immunity

Stephanie Y. Owyang et al.

IMMUNOLOGY LETTERS (2017)

Article Nanoscience & Nanotechnology

Modified nanoparticle mediated IL-12 immunogene therapy for colon cancer

Xiaoxiao Liu et al.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)

Article Immunology

Molecular Signatures of Human Regulatory T Cells in Colorectal Cancer and Polyps

Nor Adzimah Johdi et al.

FRONTIERS IN IMMUNOLOGY (2017)

Article Immunology

Defective IL-23/IL-17 Axis Protects p47phox-/-Mice from Colon Cancer

Cornelia Richter et al.

Frontiers in Immunology (2017)

Review Immunology

Anti-Adhesion Therapies in inflammatory Bowel Disease-Molecular and Clinical Aspects

Sebastian Zundler et al.

FRONTIERS IN IMMUNOLOGY (2017)

Correction Immunology

IL-6 as a keystone cytokine in health and disease (vol 16, pg 448, 2015)

Christopher A. Hunter et al.

NATURE IMMUNOLOGY (2017)

Article Gastroenterology & Hepatology

Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancer

Elise Punkenburg et al.

Article Biochemistry & Molecular Biology

Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers

Takuro Saito et al.

NATURE MEDICINE (2016)

Article Biochemistry & Molecular Biology

Deficiency of Interferon-Gamma or Its Receptor Promotes Colorectal Cancer Development

Lu Wang et al.

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2015)

Article Multidisciplinary Sciences

Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity

Stefani Spranger et al.

NATURE (2015)

Article Genetics & Heredity

Stromal gene expression defines poor-prognosis subtypes in colorectal cancer

Alexandre Calon et al.

NATURE GENETICS (2015)

Article Biochemistry & Molecular Biology

Upregulation of TLRs and IL-6 as a Marker in Human Colorectal Cancer

Chien-Chang Lu et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)

Review Medicine, General & Internal

NK cell inflammation in the clinical outcome of colorectal carcinoma

Andrea Coppola et al.

FRONTIERS IN MEDICINE (2015)

Review Immunology

Immune Escape Mechanisms in Colorectal Cancer Pathogenesis and Liver Metastasis

Massimo Pancione et al.

JOURNAL OF IMMUNOLOGY RESEARCH (2014)

Review Oncology

Control of the immune response by pro-angiogenic factors

Thibault Voron et al.

FRONTIERS IN ONCOLOGY (2014)

Review Oncology

Role of TH17 cytokines in the control of colorectal cancer

Veronica De Simone et al.

ONCOIMMUNOLOGY (2013)

Article Critical Care Medicine

CD14+S100A9+ Monocytic Myeloid-derived Suppressor Cells and Their Clinical Relevance in Non-Small Cell Lung Cancer

Po-Hao Feng et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)

Article Medicine, Research & Experimental

The prognostic significance of chemokine receptor CXCR3 expression in colorectal carcinoma

Zhenqian Wu et al.

BIOMEDICINE & PHARMACOTHERAPY (2012)

Article Biochemistry & Molecular Biology

Anticancer Properties of the IL-12 Family - Focus on Colorectal Cancer

M. A. Engel et al.

CURRENT MEDICINAL CHEMISTRY (2012)

Article Multidisciplinary Sciences

Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth

Sergei I. Grivennikov et al.

NATURE (2012)

Review Immunology

IL-12 family cytokines: immunological playmakers

Dario A. A. Vignali et al.

NATURE IMMUNOLOGY (2012)

Article Gastroenterology & Hepatology

IL-17A in the tumor microenvironment of the human colorectal adenoma-carcinoma sequence

Guanglin Cui et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)

Article Cell & Tissue Engineering

CXCR6: The Role of Environment in Tumor Progression. Challenges for Therapy

Caterina A. M. La Porta

STEM CELL REVIEWS AND REPORTS (2012)

Review Biochemistry & Molecular Biology

IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer

Markus F. Neurath et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2011)

Article Gastroenterology & Hepatology

IL-23/IL-23R: potential mediator of intestinal tumor progression from adenomatous polyps to colorectal carcinoma

Feng Lan et al.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2011)

Review Cell Biology

Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy

Pravin Mishra et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2011)

Article Gastroenterology & Hepatology

Low expression of chemokine receptor CCR5 in human colorectal cancer correlates with lymphatic dissemination and reduced CD8(+) T-cell infiltration

Tim Zimmermann et al.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2010)

Review Immunology

Transcriptional regulation of the mucosal immune system mediated by T-bet

N. Powell et al.

MUCOSAL IMMUNOLOGY (2010)

Article Biochemistry & Molecular Biology

Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes

K. Kawada et al.

ONCOGENE (2007)

Review Gastroenterology & Hepatology

Review article: immune suppression and colorectal cancer

C. Evans et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)

Article Oncology

Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer

P Ghadjar et al.

JOURNAL OF CLINICAL ONCOLOGY (2006)

Review Biochemistry & Molecular Biology

TGF-beta as a T cell regulator in colitis and colon cancer

C Becker et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2006)

Article Medicine, General & Internal

Effector memory T cells, early metastasis, and survival in colorectal cancer

F Pagès et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Review Biochemistry & Molecular Biology

Macrophage inflammatory protein-1

P Menten et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2002)